Daptomycin-based aminoglycoside-sparing therapy for streptococcal endocarditis: a retrospective multicenter study
Authors:
- 25 October 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 33 (6) , 435-439
Abstract
Streptococci still represent common etiologic agents of infective endocarditis (IE). Although renal failure is frequently reported as an aminoglycoside-associated adverse event, last international guidelines recommend a beta-lactam/gentamicin combination therapy. We retrospectively evaluated the use of daptomycin-based aminoglycoside-sparing combination therapy for the treatment of streptococcal IE in seven referral hospitals in Italy. Retrospective, multicenter, observational study. All patients with streptococcal IE admitted from 2016 to 2018 were enrolled. Mortality and incidence of acute kidney injury (AKI) were compared between Group A (standard of care, SoC) and Group B (daptomycin-based aminoglycoside-sparing combination therapy). Fifty-four patients were enrolled, 33 in Group A and 21 in Group B. Mortality was 2/33 (6%) in Group A and 0 in Group B (p = 0.681); AKI incidence was 8/33 (24%) in Group A and 0 in Group B (p = 0.04). Daptomycin-based aminoglycoside-sparing combination therapy appears to be promising for the treatment of streptococcal endocarditis because of similar efficacy compared with SoC and significantly reduced incidence of AKI.Keywords
This publication has 17 references indexed in Scilit:
- Is Penicillin Plus Gentamicin Synergistic against Clinical Group B Streptococcus isolates?: An In vitro StudyFrontiers in Microbiology, 2016
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsCirculation, 2015
- 2015 ESC Guidelines for the management of infective endocarditisEuropean Heart Journal, 2015
- Characterization of High-Level Daptomycin Resistance in Viridans Group Streptococci Developed upon In Vitro Exposure to DaptomycinAntimicrobial Agents and Chemotherapy, 2015
- Daptomycin Activity against Uncommonly Isolated Streptococcal and Other Gram-Positive Species GroupsAntimicrobial Agents and Chemotherapy, 2013
- Early In Vitro and In Vivo Development of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to DaptomycinAntimicrobial Agents and Chemotherapy, 2013
- Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial EndocarditisAntimicrobial Agents and Chemotherapy, 2013
- Synergy Between Penicillins and Low Concentrations of Gentamicin in the Killing of Group B StreptococciThe Journal of Infectious Diseases, 1985
- Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococciAntimicrobial Agents and Chemotherapy, 1981
- Synergistic Effects of Ampicillin-Aminoglycoside Combinations on Group B StreptococciAntimicrobial Agents and Chemotherapy, 1979